Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers | British Journal of Cancer
Paclitaxel - wikidoc
Nab-Paclitaxel: A Novel Formulation of Taxane for Treatment of Breast Cancer - Prakash Vishnu, Vivek Roy, 2010
Paclitaxel Injection (Patient Information Included) Rx only
Paclitaxel | C47H51NO14 | CID 36314 - PubChem
Paclitax Nab ( PACLITAXEL ) at Rs 5500/vial | Anzatax in Nagpur | ID: 22218144173
ecancermedicalscience - FDA approves #atezolizumab with nab-paclitaxel and carboplatin for metastatic #NSCLC without EGFR/ALK aberrations. Read more here: http://bit.ly/33PZaec #Immunotherapy #Oncology #IMpower130 | Facebook
Paclitaxel (MSN LABORATORIES PRIVATE LIMITED): FDA Package Insert, Page 7
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial - The Lancet Oncology
Frontiers | Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1–positive advanced cervical cancer: a phase II, single-arm study
nab-Paclitaxel mechanisms of action and delivery - ScienceDirect
Biomolecules | Free Full-Text | Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
The Results of Phase II Clinical Study of KN046 in Combination with Nab- paclitaxel in TNBC were Published in Nature Communications
Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System - Misa Naganuma, Kohei Tahara, Shiori Hasegawa, Akiho Fukuda, Sayaka Sasaoka, Haruna
Paclitaxel Protein-Bound Particles / Products / American Regent
Biomedicines | Free Full-Text | Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer | Molecular Pharmaceutics
Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial - eBioMedicine
Paclitaxel Concentrate Injection: Package Insert - Drugs.com
Frontiers | Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
Paclitaxel Injection, USP
Biomedicines | Free Full-Text | Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety
Full article: Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
Paclitaxel Concentrate Injection: Package Insert - Drugs.com
Sun BioPharma's pancreatic cancer therapy gets US FDA's fast-track status | S&P Global Market Intelligence
Pharmaceutics | Free Full-Text | Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs
Paclitaxel (Hospira, Inc.): FDA Package Insert, Page 7
